Researchers at University of California San Diego School of Medicine discovered that they can block inflammation in mice with a naturally occurring antibody that binds oxidized phospholipids (OxPL), molecules on cell surfaces that get modified by inflammation. Even while on a high-fat diet, the antibody protected the mice from arterial plaque formation, hardening of the arteries and liver disease, and prolonged their lives.
This study, published June 6 by Nature, marks the first demonstration in a living system that OxPL triggers inflammation and leads to plaque formation. The results also suggest a new approach for preventing or reversing a number of inflammatory diseases.
“Wherever you get inflammation, you get OxPL,” said senior author Joseph Witztum, MD, professor of medicine at UC San Diego School of Medicine. “It doesn’t mean OxPL is the cause, but it definitely plays a major role.” Witztum led the study with first author Xuchu Que, PhD, a senior project scientist at UC San Diego School of Medicine.
Some phospholipids — the molecules that make up cell membranes — are prone to modification by reactive oxygen species, forming OxPL. This event is particularly common in inflammatory conditions such as atherosclerosis, in which artery-blocking plaques form. Prior to this study, researchers were unable to control phospholipid oxidation in a way that would allow them to study its role in inflammation and atherosclerosis.
Witztum, Que and team engineered mice with two special attributes: 1) they have a gene mutation that makes them a good model for atherosclerosis and 2) they generate a piece of an antibody called E06 that’s just enough to bind OxPL and prevent their ability to cause inflammation in immune cells, but not enough to cause inflammation on its own. They fed the mice a high-fat diet.
Here’s what happened: Compared to control mice, the mice with E06 antibodies had 28 to 57 percent less atherosclerosis, even after one year and despite having high levels of cholesterol. The antibody also decreased aortic valve calcification (hardening and narrowing of the aortic valves), hepatic steatosis (fatty liver disease) and liver inflammation. E06 antibody-producing mice had 32 percent less serum amyloid A, a marker of systemic inflammation.
The E06 antibody also prolonged the life of the mice. After 15 months, all of the E06 antibody-producing mice were alive, compared to 54 percent of the control mice.
“We showed for the first time that OxPL are truly pro-inflammatory and pro-atherogenic and, moreover, that they can be counteracted by E06 antibody,” Witztum said. “This suggests that therapies that inactivate OxPL may be beneficial for reducing inflammation in general, and in particular in the case of diseases such as atherosclerosis, aortic stenosis and hepatic steatosis.”
Witztum and team are now testing E06 antibody in mouse models of human diseases linked to inflammation, such as osteoporosis (bone loss) and nonalcoholic steatohepatitis (NASH, a type of liver disease).
The Latest on: Inflammation
via Google News
The Latest on: Inflammation
- The Best Juice to Sip on To Reduce Inflammation, Says Dietitianon August 1, 2022 at 12:57 pm
This unexpected juice is highly recommended for sports recovery and reducing inflammation in the body. The post The Best Juice to Sip on To Reduce Inflammation, Says Dietitian appeared first on The ...
- Leaky gut: Green tea may help reduce gut inflammation, blood sugaron July 31, 2022 at 7:41 pm
The study shows consuming green tea extract may reduce blood sugar levels and decrease gut inflammation and permeability. Researchers reported that both participants with metabolic syndrome and ...
- Your Personal Best: Anti-inflammation foodson July 29, 2022 at 12:52 pm
By WVUA Reporter Kyle Hamrick Many people with arthritis or overuse injuries know about inflammation. But many may not know that certain foods can make inflammation worse. “Foods that are high in ...
- How ADAR1 mutation leads to self-destructive inflammationon July 28, 2022 at 9:37 am
A new study shows how mutation of the ADAR1 gene sets off biochemical pathways that produce an autoimmune response that harms the developing brain and other areas of the body.
- Scientists discover a surprising link between mitochondria, inflammation and DNMT3A and TET2 geneson July 26, 2022 at 10:54 am
Mitochondria are known as cells' powerhouses, but mounting evidence suggests they also play a role in inflammation. Scientists from the Salk Institute and UC San Diego published new findings in ...
- Hydrogen generated by Si-based agent attenuates inflammation in ulcerative colitis mouse modelon July 25, 2022 at 6:48 am
Many people worldwide suffer from a chronic type of inflammatory bowel disease (IBD) called ulcerative colitis (UC), which is characterized by erosions and ulcers within the mucous membrane of the ...
- Navidea Biopharmaceuticals Announces Publication of Study Examining Tc99m Tilmanocept Imaging of Arterial Inflammation in People with HIVon July 25, 2022 at 4:30 am
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced ...
- The good news, and bad news, of inflammationon July 24, 2022 at 8:34 am
Is the body's response to injury good for you, or is it bad? It depends. Following short-term injury, infection and exercise, inflammation is your friend. In chronic, low-dose form, it may be to blame ...
- Alector, INmune Bio, Inflammation, And Alzheimer's Disease: One Piece Of The Puzzleon July 22, 2022 at 12:35 pm
INmune Bio and Alector are seeking to treat Alzheimer's disease by decreasing neuroinflammation while maintaining a healthy immune response. Read more here.
via Bing News